Retinoic acid reduces glucocorticoid sensitivity in C2C12 myotubes by decreasing 11β-hydroxysteroid dehydrogenase type 1 and glucocorticoid receptor activities

Endocrinology

Volumn 150, Issue 6, 2009, Pages 2700-2708

  Aubry, Evelyne M ^a,b   Odermatt, Alex ^a,b  

^a UNIVERSITY OF BASEL   (Switzerland)

^b UNIVERSITY OF BERN   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

11BETA HYDROXYSTEROID DEHYDROGENASE 1; GLUCOCORTICOID RECEPTOR; MESSENGER RNA; RETINOIC ACID; RETINOIC ACID RECEPTOR; RETINOIC ACID RECEPTOR GAMMA;

ANIMAL CELL; ARTICLE; CONTROLLED STUDY; DOWN REGULATION; ENZYME ACTIVITY; HORMONAL REGULATION; MOUSE; MUSCLE DEVELOPMENT; MYOBLAST; MYOTUBE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION;

11-BETA-HYDROXYSTEROID DEHYDROGENASE TYPE 1; ANIMALS; CELL DIFFERENTIATION; CELL LINE; DOSE-RESPONSE RELATIONSHIP, DRUG; DOWN-REGULATION; GLUCOCORTICOIDS; KERATOLYTIC AGENTS; MICE; MODELS, ANIMAL; MUSCLE DEVELOPMENT; MUSCLE FIBERS, SKELETAL; MUSCLE, SKELETAL; OROSOMUCOID; RECEPTORS, GLUCOCORTICOID; RECEPTORS, RETINOIC ACID; RNA, MESSENGER; TRANSCRIPTIONAL ACTIVATION; TRETINOIN; TUMOR NECROSIS FACTOR-ALPHA;

EID: 66649122851     PISSN: 00137227     EISSN: 00137227     Source Type: Journal    
DOI: 10.1210/en.2008-1618     Document Type: Article

References (47)

1. Liu Z, Long W, Fryburg DA, Barrett EJ 2006 The regulation of body and skeletal muscle protein metabolism by hormones and amino acids. J Nutr 136(Suppl):212S-217S
2. Pirlich M, Biering H, Gerl H, Ventz M, Schmidt B, Ertl S, Lochs H 2002 Loss of body cell mass in Cushing's syndrome: effect of treatment. J Clin Endocrinol Metab 87:1078-1084
3. Schäcke H, Döcke WD, Asadullah K 2002 Mechanisms involved in the side effects of glucocorticoids. Pharmacol Ther 96:23-43
4. Tomlinson JW, Stewart PM 2007 Modulation of glucocorticoid action and the treatment of type-2 diabetes. Best Pract Res Clin Endocrinol Metab 21:607-619
5. Atanasov AG, Odermatt A 2007 Readjusting the glucocorticoid balance: an opportunity for modulators of 11β-hydroxysteroid dehydrogenase type 1 activity? Endocr Metab Immune Disord Drug Targets 7:125-140
6. Masuzaki H, Paterson J, Shinyama H, Morton NM, Mullins JJ, Seckl JR, Flier JS 2001 A transgenic model of visceral obesity and the metabolic syndrome. Science 294:2166-2170
7. Masuzaki H, Yamamoto H, Kenyon CJ, Elmquist JK, Morton NM, Paterson JM, Shinyama H, Sharp MG, Fleming S, Mullins JJ, Seckl JR, Flier JS 2003 Transgenic amplification of glucocorticoid action in adipose tissue causes high blood pressure in mice. J Clin Invest 112:83-90
8. Kotelevtsev Y, Holmes MC, Burchell A, Houston PM, Schmoll D, Jamieson P, Best R, Brown R, Edwards CR, Seckl JR, Mullins JJ 1997 11β-Hydroxysteroid dehydrogenase type 1 knockout mice show attenuated glucocorticoid-inducible responses and resist hyperglycemia on obesity or stress. Proc Natl Acad Sci USA 94:14924-14929
9. Jang C, Obeyesekere VR, Dilley RJ, Alford FP, Inder WJ 2006 11β Hydroxysteroid dehydrogenase type 1 is expressed and is biologically active in human skeletal muscle. Clin Endocrinol (Oxf) 65:800-805
10. Abdallah BM, Beck-Nielsen H, Gaster M 2005 Increased expression of 11β-hydroxysteroid dehydrogenase type 1 in type 2 diabetic myotubes. Eur J Clin Invest 35:627-634
11. Whorwood CB, Donovan SJ, Flanagan D, Phillips DI, Byrne CD 2002 Increased glucocorticoid receptor expression in human skeletal muscle cells may contribute to the pathogenesis of the metabolic syndrome. Diabetes 51:1066-1075
12. Blomhoff R, Blomhoff HK 2006 Overview of retinoid metabolism and function. J Neurobiol 66:606-630
13. Ziouzenkova O, Orasanu G, Sharlach M, Akiyama TE, Berger JP, Viereck J, Hamilton JA, Tang G, Dolnikowski GG, Vogel S, Duester G, Plutzky J 2007 Retinaldehyde represses adipogenesis and diet-induced obesity. Nat Med 13:695-702
14. Felipe F, Bonet ML, Ribot J, Palou A 2004 Modulation of resistin expression by retinoic acid and vitamin A status. Diabetes 53:882-889
15. Puigserver P, Vazquez F, Bonet ML, Pico C, Palou A 1996 In vitro and in vivo induction of brown adipocyte uncoupling protein (thermogenin) by retinoic acid. Biochem J 317(Pt 3):827-833
16. Sakuta T, Uchiyama T, Kanayama T 2006 Topical ER36009, a RAR γ-selective retinoid, decreases abdominal white adipose tissue and elicits changes in expression of genes related to adiposity and thermogenesis. Endocrine 30:113-119
17. Amengual J, Ribot J, Bonet ML, Palou A 2008 Retinoic acid treatment increases lipid oxidation capacity in skeletal muscle of mice. Obesity (Silver Spring) 16:585-591
18. Solanes G, Pedraza N, Iglesias R, Giralt M, Villarroya F 2000 The human uncoupling protein-3 gene promoter requires MyoD and is induced by retinoic acid in muscle cells. FASEB J 14:2141-2143
19. Mangelsdorf DJ 1994 Vitamin A receptors. Nutr Rev 52(2 Pt 2):S32-S44 (Pubitemid 24094021)
20. Halevy O, Lerman O 1993 Retinoic acid induces adult muscle cell differentiation mediated by the retinoic acid receptor-α. J Cell Physiol 154:566-572
21. Albagli-Curiel O, Carnac G, Vandromme M, Vincent S, Crépieux P, Bonnieu A 1993 Serum-induced inhibition of myogenesis is differentially relieved by retinoic acid and triiodothyronine in C2 murine muscle cells. Differentiation 52:201-210
22. Stulnig TM, Oppermann U, Steffensen KR, Schuster GU, Gustafsson JA 2002 Liver X receptors downregulate 11 β-hydroxysteroid dehydrogenase type 1 expression and activity. Diabetes 51:2426-2433
23. Livak KJ, Schmittgen TD 2001 Analysis of relative gene expression data using real-time quantitative PCR and the 2(-δδC(T)) method. Methods 25:402-408
24. Lowry OH, Rosebrough NJ, Farr AL, Randall RJ 1951 Protein measurement with the Folin phenol reagent. J Biol Chem 193:265-275
25. Schuster D, Maurer EM, Laggner C, Nashev LG, Wilckens T, Langer T, Odermatt A 2006 The discovery of new 11 β-hydroxysteroid dehydrogenase type 1 inhibitors by common feature pharmacophore modeling and virtual screening. J Med Chem 49:3454-3466
26. Chambon P 1996 A decade of molecular biology of retinoic acid receptors. FASEB J 10:940-954 (Pubitemid 26285969)
27. Keidel S, LeMotte P, Apfel C 1994 Different agonist- and antagonist-induced conformational changes in retinoic acid receptors analyzed by protease mapping. Mol Cell Biol 14:287-298
28. Savoldi G, Fenaroli A, Ferrari F, Rigaud G, Albertini A, Di Lorenzo D 1997 The glucocorticoid receptor regulates the binding of C/EPBβ on the α-1-acid glycoprotein promoter in vivo. DNA Cell Biol 16:1467-1476
29. Arampatzis S, Kadereit B, Schuster D, Balazs Z, Schweizer RA, Frey FJ, Langer T, Odermatt A 2005 Comparative enzymology of 11 β-hydroxysteroid dehydrogenase type 1 from six species. J Mol Endocrinol 35:89-101
30. Hermanowski-Vosatka A, Balkovec JM, Cheng K, Chen HY, Hernandez M, Koo GC, Le Grand CB, Li Z, Metzger JM, Mundt SS, Noonan H, Nunes CN, Olson SH, Pikounis B, Ren N, Robertson N, Schaeffer JM, Shah K, Springer MS, Strack AM, Strowski M, Wu K, Wu T, Xiao J, Zhang BB, Wright SD, Thieringer R 2005 11β-HSD1 inhibition ameliorates metabolic syndrome and prevents progression of atherosclerosis in mice. J Exp Med 202:517-527
31. Berger J, Tanen M, Elbrecht A, Hermanowski-Vosatka A, Moller DE, Wright SD, Thieringer R 2001 Peroxisome proliferator-activated receptor-γ ligands inhibit adipocyte 11β-hydroxysteroid dehydrogenase type 1 expression and activity. J Biol Chem 276:12629-12635
32. Hermanowski-Vosatka A, Gerhold D, Mundt SS, Loving VA, Lu M, Chen Y, Elbrecht A, Wu M, Doebber T, Kelly L, Milot D, Guo Q, Wang PR, Ippolito M, Chao YS, Wright SD, Thieringer R 2000 PPARα agonists reduce 11 β-hydroxysteroid dehydrogenase type 1 in the liver. Biochem Biophys Res Commun 279:330-336
33. Csaba G, Gaá l A, Inczefi-Gonda A 1999 The effect of perinatal hormonal imprinting with 13-cis-retinoic acid (isotretinoin) on the thymic glucocorticoid receptors of female and testosterone level of male adult rats. Horm Metab Res 31:505-507
34. Rebuffat AG, Tam S, Nawrocki AR, Baker ME, Frey BM, Frey FJ, Odermatt A 2004 The 11-ketosteroid 11-ketodexamethasone is a glucocorticoid receptor agonist. Mol Cell Endocrinol 214:27-37
35. Ribot J, Felipe F, Bonet ML, Palou A 2001 Changes of adiposity in response to vitamin A status correlate with changes of PPARγ2 expression. Obes Res 9:500-509
36. Kumar MV, Scarpace PJ 1998 Differential effects of retinoic acid on uncoupling protein-1 and leptin gene expression. J Endocrinol 157:237-243
37. Tsutsumi C, Okuno M, Tannous L, Piantedosi R, Allan M, Goodman DS, Blaner WS 1992 Retinoids and retinoid-binding protein expression in rat adipocytes. J Biol Chem 267:1805-1810
38. Rainey WE 1999 Adrenal zonation: clues from 11[β]-hydroxylase and aldosterone synthase. Mol Cell Endocrinol 151:151-160
39. Rajan V, Chapman KE, Lyons V, Jamieson P, Mullins JJ, Edwards CR, Seckl JR 1995 Cloning, sequencing and tissue-distribution of mouse 11β-hydroxysteroid dehydrogenase-1 cDNA. J Steroid Biochem Mol Biol 52:141-147
40. Rask E, Olsson T, Söderberg S, Andrew R, Livingstone DE, Johnson O, Walker BR 2001 Tissue-specific dysregulation of cortisol metabolism in human obesity. J Clin Endocrinol Metab 86:1418-1421
41. Mercader J, Madsen L, Felipe F, Palou A, Kristiansen K, Bonet ML 2007 All-trans retinoic acid increases oxidative metabolism in mature adipocytes. Cell Physiol Biochem 20:1061-1072
42. Whorwood CB, Donovan SJ, Wood PJ, Phillips DIW 2001 Regulation of glucocorticoid receptor α and β isoforms and type I 11 β-hydroxysteroid dehydrogenase expression in human skeletal muscle cells: a key role in the pathogenesis of insulin resistance? J Clin Endocrinol Metab 86:2296-2308
43. Carlberg C 1993 RXR-independent action of the receptors for thyroid hormone, retinoid acid and vitamin D on inverted palindromes. Biochem Biophys Res Commun 195:1345-1353 (Pubitemid 23290301)
44. Stio M, Celli A, Treves C 2002 Synergistic effect of vitamin D derivatives and retinoids on C2C12 skeletal muscle cells. IUBMB Life 53:175-181
45. Gu X, Ke S, Liu D, Sheng T, Thomas PE, Rabson AB, Gallo MA, Xie W, Tian Y 2006 Role of NF-κB in regulation of PXR-mediated gene expression: a mechanism for the suppression of cytochrome P-450 3A4 by proinflammatory agents. J Biol Chem 281:17882-17889
46. Chawla A, Lazar MA 1994 Peroxisome proliferator and retinoid signaling pathways co-regulate preadipocyte phenotype and survival. Proc Natl Acad Sci USA 91:1786-1790
47. Tremblay J, Hardy DB, Pereira LE, Yang K 1999 Retinoic acid stimulates the expression of 11β-hydroxysteroid dehydrogenase type 2 in human choriocarcinoma JEG-3 cells. Biol Reprod 60:541-545